Santos Jorge L, Choquette Monique, Bezerra Jorge A
Hospital de Clinicas and Federal University of Rio Grande do Sul, Rua Ramiro Barcelos, Bairro Rio Branco, Porto Alegre, RS, Brazil.
Curr Gastroenterol Rep. 2010 Feb;12(1):30-9. doi: 10.1007/s11894-009-0081-8.
Inherited syndromes of intrahepatic cholestasis and biliary atresia are the most common causes of chronic liver disease and the prime indication for liver transplantation in children. Our understanding of the pathogenesis of these diseases has increased substantially by the discovery of genetic mutations in children with intrahepatic cholestasis and the findings that inflammatory circuits are operative at the time of diagnosis of biliary atresia. Building on this solid foundation, recent studies provide new insight into genotype-phenotype relationships and how mutations produce altered bile composition and cholestasis. New evidence exists that although liver transplantation is curative for patients with end-stage liver disease owing to cholestasis, some patients may develop recurrence of cholestasis because of the emergence of autoantibodies that disrupt canalicular function in the new graft. Progress is also evident in biliary atresia, with recent studies identifying candidate modifier genes and directly implicating lymphocytes and inflammatory signals in the pathogenesis of bile duct injury and obstruction.
遗传性肝内胆汁淤积综合征和胆道闭锁是儿童慢性肝病最常见的病因,也是儿童肝移植的主要指征。随着肝内胆汁淤积患儿基因突变的发现以及胆道闭锁诊断时炎症通路起作用这一发现,我们对这些疾病发病机制的认识有了显著提高。基于这一坚实基础,最近的研究为基因型-表型关系以及突变如何导致胆汁成分改变和胆汁淤积提供了新的见解。新的证据表明,尽管肝移植可治愈因胆汁淤积导致的终末期肝病患者,但由于新移植肝脏中出现破坏胆小管功能的自身抗体,一些患者可能会出现胆汁淤积复发。胆道闭锁方面也有明显进展,最近的研究确定了候选修饰基因,并直接表明淋巴细胞和炎症信号与胆管损伤和梗阻的发病机制有关。